These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9520115)

  • 21. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
    Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S).
    Faergeman O; Kjekshus J; Cook T; Pyörälä K; Wilhelmsen L; Thorgeirsson G; Pedersen TR
    Eur Heart J; 1998 Oct; 19(10):1531-7. PubMed ID: 9820992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
    Larsen ML
    Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein(a) screening in patients with controlled traditional risk factors undergoing percutaneous coronary intervention.
    Weiss MC; Berger JS; Gianos E; Fisher E; Schwartzbard A; Underberg J; Weintraub H
    J Clin Lipidol; 2017; 11(5):1177-1180. PubMed ID: 28801030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).
    Girman CJ; Rhodes T; Mercuri M; Pyörälä K; Kjekshus J; Pedersen TR; Beere PA; Gotto AM; Clearfield M;
    Am J Cardiol; 2004 Jan; 93(2):136-41. PubMed ID: 14715336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.
    Luc G; Bard JM; Arveiler D; Ferrieres J; Evans A; Amouyel P; Fruchart JC; Ducimetiere P;
    Atherosclerosis; 2002 Aug; 163(2):377-84. PubMed ID: 12052486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
    Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
    Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
    Tonkin AM
    Am J Cardiol; 1995 Sep; 76(9):107C-112C. PubMed ID: 7572678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.
    Jauhiainen M; Koskinen P; Ehnholm C; Frick MH; Mänttäri M; Manninen V; Huttunen JK
    Atherosclerosis; 1991 Jul; 89(1):59-67. PubMed ID: 1837713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low high-density lipoprotein cholesterol and response to simvastatin therapy in Scandinavian Simvastatin Survival Study (4S).
    Robins S
    Circulation; 2002 Jul; 106(2):e8; author reply e8. PubMed ID: 12105176
    [No Abstract]   [Full Text] [Related]  

  • 31. Statin trials and goals of cholesterol-lowering therapy after AMI.
    Pedersen TR
    Am Heart J; 1999 Aug; 138(2 Pt 2):S177-82. PubMed ID: 10426879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk.
    Gonbert S; Malinsky S; Sposito AC; Laouenan H; Doucet C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Oct; 164(2):305-11. PubMed ID: 12204802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study.
    Fogacci F; Cicero AF; D'Addato S; D'Agostini L; Rosticci M; Giovannini M; Bertagnin E; Borghi C;
    Eur J Intern Med; 2017 Jan; 37():49-55. PubMed ID: 27553697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
    Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study.
    Parish S; Hopewell JC; Hill MR; Marcovina S; Valdes-Marquez E; Haynes R; Offer A; Pedersen TR; Baigent C; Collins R; Landray M; Armitage J;
    Circ Genom Precis Med; 2018 Feb; 11(2):e001696. PubMed ID: 29449329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
    Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
    Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients.
    Cressman MD; Heyka RJ; Paganini EP; O'Neil J; Skibinski CI; Hoff HF
    Circulation; 1992 Aug; 86(2):475-82. PubMed ID: 1386292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lp(a) lipoprotein, vascular disease, and mortality in the elderly.
    Ariyo AA; Thach C; Tracy R;
    N Engl J Med; 2003 Nov; 349(22):2108-15. PubMed ID: 14645638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study.
    Herman WH; Alexander CM; Cook JR; Boccuzzi SJ; Musliner TA; Pedersen TR; Kjekshus J; Pyörälä K
    Diabetes Care; 1999 Nov; 22(11):1771-8. PubMed ID: 10546006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study.
    Hopkins PN; Hunt SC; Schreiner PJ; Eckfeldt JH; Borecki IB; Ellison CR; Williams RR; Siegmund KD
    Atherosclerosis; 1998 Dec; 141(2):333-45. PubMed ID: 9862182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.